Adagio Therapeutics Inc (NASDAQ:ADGI)

2.96
Delayed Data
As of May 20
 -0.01 / -0.34%
Today’s Change
2.46
Today|||52-Week Range
78.82
-59.23%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Adagio Therapeutics Inc have a median target of 3.50, with a high estimate of 5.00 and a low estimate of 3.00. The median estimate represents a +18.24% increase from the last price of 2.96.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Hold stock in Adagio Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.53
Sales
$0.00
Reporting Date
Sep 19

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 43.01%
 
 
 
 
 
 
Growthannually 58.46%
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
Key to the earnings and sales forecast charts.